The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

Non-animal testing methods could save drugmakers time and money, officials say ...

The Asian Development Bank’s Technology Innovation Challenge funds pilot projects that test new technologies to solve ...

The following is the Office of the Director, Operational Test & Evaluation (DOT&E) 2025 annual report. The report was ...

Sauce Labs says its approach to testing, based on business intent, can help enterprises break the logjam caused by the need for quality assurance in software development ...

In my experience, hypergrowth often masks a bigger crisis: skimping on testing discipline. From what I've seen, early-stage teams rarely struggle with quality. Small engineering groups share context ...

Stringer Outdoor Co LLC, operating under the trade name Treow Outdoors™, has completed development of its Cocoon ...

The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. | The FDA's newest draft guidance reinforces its previous commitment to streamlining biosimilar drug ...

Overview: Go delivers high-performance backend services with efficient resource usage and faster response.Built-in concurrency with goroutines enables scalable ...

Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental ...

HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the animal testing requirement for monoclonal antibodies. A few months later, ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...